Sunshine Biopharma Inc.

03/27/2011 | Press release | Archived content

SUNSHINE BIOPHARMA’S LEAD ANTI CANCER COMPOUND, ADVA 27A, PERFORMS EXCEPTIONALLY WELL IN HUMAN MICROSOME STABILITY ASSAYS